519 related articles for article (PubMed ID: 15205947)
1. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
Qin LX; Tang ZY
J Cancer Res Clin Oncol; 2004 Sep; 130(9):497-513. PubMed ID: 15205947
[TBL] [Abstract][Full Text] [Related]
2. The prognostic molecular markers in hepatocellular carcinoma.
Qin LX; Tang ZY
World J Gastroenterol; 2002 Jun; 8(3):385-92. PubMed ID: 12046056
[TBL] [Abstract][Full Text] [Related]
3. A decade's studies on metastasis of hepatocellular carcinoma.
Tang ZY; Ye SL; Liu YK; Qin LX; Sun HC; Ye QH; Wang L; Zhou J; Qiu SJ; Li Y; Ji XN; Liu H; Xia JL; Wu ZQ; Fan J; Ma ZC; Zhou XD; Lin ZY; Liu KD
J Cancer Res Clin Oncol; 2004 Apr; 130(4):187-96. PubMed ID: 14685850
[TBL] [Abstract][Full Text] [Related]
4. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
[TBL] [Abstract][Full Text] [Related]
5. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
6. Specific molecular markers in hepatocellular carcinoma.
Yao DF; Dong ZZ; Yao M
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):241-7. PubMed ID: 17548245
[TBL] [Abstract][Full Text] [Related]
7. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.
Kim H; Park YN
Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296
[TBL] [Abstract][Full Text] [Related]
11. Screening candidate metastasis-associated genes in three-dimensional HCC spheroids with different metastasis potential.
Chen R; Dong Y; Xie X; Chen J; Gao D; Liu Y; Ren Z; Cui J
Int J Clin Exp Pathol; 2014; 7(5):2527-35. PubMed ID: 24966965
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs involved with hepatocellular carcinoma (Review).
Mao B; Wang G
Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
[TBL] [Abstract][Full Text] [Related]
13. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805
[TBL] [Abstract][Full Text] [Related]
15. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.
Van Hees S; Michielsen P; Vanwolleghem T
World J Gastroenterol; 2016 Oct; 22(37):8271-8282. PubMed ID: 27729734
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.
Kanda M; Sugimoto H; Kodera Y
World J Gastroenterol; 2015 Oct; 21(37):10584-97. PubMed ID: 26457018
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
[TBL] [Abstract][Full Text] [Related]
19. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinoma.
Shirahashi H; Sakaida I; Terai S; Hironaka K; Kusano N; Okita K
Liver; 2002 Oct; 22(5):413-8. PubMed ID: 12458564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
